scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1049628503 |
P356 | DOI | 10.1186/1471-2407-12-169 |
P932 | PMC publication ID | 3493289 |
P698 | PubMed publication ID | 22559235 |
P5875 | ResearchGate publication ID | 224911825 |
P50 | author | Lars A. Akslen | Q11983239 |
Helga Salvesen | Q27506003 | ||
Marsha A. Moses | Q89418306 | ||
Ingunn M Stefansson | Q114398050 | ||
Monica Mannelqvist | Q125333058 | ||
P2093 | author name string | Elisabeth Wik | |
Anne M Øyan | |||
Kanthida Kusonmano | |||
Karl-Henning Kalland | |||
Maria B Raeder | |||
P2860 | cites work | The lipocalin protein family: structure and function | Q24529878 |
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells | Q24672969 | ||
Lipocalins and cancer | Q28142718 | ||
SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism | Q28589595 | ||
Laser-captured microdissection-microarray analysis of the genes involved in endometrial carcinogenesis: stepwise up-regulation of lipocalin2 expression in normal and neoplastic endometria and its functional relevance | Q33824652 | ||
Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis | Q33969500 | ||
Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients | Q34394727 | ||
Lipocalin-2-induced cytokine production enhances endometrial carcinoma cell survival and migration | Q34535859 | ||
Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer | Q34760721 | ||
S100A8/A9 activate key genes and pathways in colon tumor progression | Q34802977 | ||
Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression | Q35141434 | ||
Tissue involution and the acute phase response | Q35157753 | ||
S100A8 and S100A9: new insights into their roles in malignancy | Q35649454 | ||
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia | Q36667422 | ||
Lipocalin 2 promotes breast cancer progression | Q37129437 | ||
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation | Q37140110 | ||
Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer | Q37174014 | ||
NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells | Q39869161 | ||
Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium | Q39909785 | ||
Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer | Q39954411 | ||
Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition | Q40172148 | ||
Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells | Q40206618 | ||
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients | Q40390256 | ||
Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation | Q40788252 | ||
The role of S100 genes in breast cancer progression | Q42481244 | ||
Serum neutrophil gelatinase-associated lipocalin in patients with colorectal liver metastases: preliminary results of an exploratory prospective study | Q43122374 | ||
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns | Q43708523 | ||
The cancer marker neutrophil gelatinase-associated lipocalin is highly expressed in human endometrial hyperplasia. | Q44362116 | ||
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast | Q44864337 | ||
GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival | Q46503741 | ||
Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells | Q46862159 | ||
Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type | Q47614641 | ||
Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer | Q47856838 | ||
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. | Q50783425 | ||
Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. | Q51829094 | ||
Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury. | Q53325234 | ||
Heterogeneous expression of the lipocalin NGAL in primary breast cancers. | Q55068164 | ||
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients | Q71169983 | ||
Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer | Q80442966 | ||
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas | Q80509584 | ||
Vascular proliferation is important for clinical progress of endometrial cancer | Q82843888 | ||
Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma | Q84565068 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 169 | |
P577 | publication date | 2012-05-06 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Lipocalin 2 expression is associated with aggressive features of endometrial cancer | |
P478 | volume | 12 |
Q37699180 | An early-screening biomarker of endometrial carcinoma: NGAL is associated with epithelio-mesenchymal transition |
Q92446478 | Associations among Serum Lipocalin-2 Concentration, Human Papilloma Virus and Clinical Stage of Cervical Cancer |
Q42706072 | Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer |
Q55241876 | Enhancer of zeste homolog 2 blockade by RNA interference is implicated with inhibited proliferation, invasion and promoted apoptosis in endometrial carcinoma. |
Q34293217 | Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma |
Q35843206 | Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma |
Q45779796 | Implications of lipocalin 2 expression in acute myeloid leukemia |
Q35833089 | Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer |
Q35034547 | Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities |
Q39138372 | Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells |
Q28068137 | Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy |
Q38388732 | Lipocalin-2 and matrix metalloproteinase-9 expression in high-grade endometrial cancer and their prognostic value |
Q39329655 | Lipocalin-2 induces apoptosis in human hepatocellular carcinoma cells through activation of mitochondria pathways |
Q28484227 | Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma |
Q41764233 | MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. |
Q50420404 | Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment |
Q37149626 | Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential. |
Q37671600 | Neutrophil gelatinase-associated lipocalin as a screening test in prostate cancer. |
Q38185940 | Prognostic biomarkers in endometrial and ovarian carcinoma |
Q92417111 | The role of lipocalin-2 in age-related macular degeneration (AMD) |
Q64079309 | The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer |
Q58126163 | [High expression of MMP20 may be a potential prognostic factor for poor outcomes of patients with endometrial carcinoma] |
Search more.